Information about ExeVir
My details
*
*
*

Company information

Status
Active

Enterprise number

BE0750.495.334

VAT liability
Yes
Established
10-07-2020
Last balance sheet year
2024
Company size
Medium-sized 9,1 FTE
Full name
ExeVir Bio
Principal activity
Research and experimental development on biotechnology
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from ExeVir

2024 2023 2022 2021
Profit/Loss -4,822,921 8 % -5,261,329 -204 % -1,731,925 94 % -27,267,284
Equity 5,616,541 -46 % 10,439,462 -34 % 15,700,791 -10 % 17,432,716
Gross margin 939,421 -59 % 2,271,646 -81 % 11,913,017 372 % 2,525,861
Employees 9.1 8.3 10.1 7.8

Publications from ExeVir

Date Publication
03-10-2025 Resignations - Appointments (NL)
28-03-2025 Resignations - Appointments (NL)
03-09-2024 Resignations - Appointments (NL)
07-06-2024 Resignations - Appointments (NL)
12-04-2024 Resignations - Appointments (NL)

Frequently asked questions

What is the VAT number of ExeVir Bio?
The VAT number of ExeVir Bio is BE 0750.495.334.
Wat is the PEPPOL ID of ExeVir Bio?
There is no information available about the PEPPOL ID of ExeVir Bio or the company is not yet registered on the PEPPOL network.
When was ExeVir Bio founded?
ExeVir Bio was founded on 10-07-2020.
What is the address of ExeVir Bio?
The current registered office of ExeVir Bio is located at Technologiepark-Zwijnaarde 94, 9052 Gent.
When was the last time ExeVir Bio filed their annual financial statements?
The most recent financial statements of ExeVir Bio were filed on 01-07-2025.
How many employees does ExeVir Bio have?
There are 9,1 FTEs working at ExeVir Bio according to the staff figures in the most recent financial statements.
What is the annual turnover of ExeVir Bio?
At the time of its most recent financial statements, ExeVir Bio did not publish any turnover figures. ExeVir Bio reported a gross margin of €939,420.69.